Shopping Cart
- Remove All
Your shopping cart is currently empty
Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $152 | Backorder | |
| 10 mg | $255 | Backorder | |
| 25 mg | $461 | Backorder | |
| 50 mg | $875 | Backorder | |
| 100 mg | $1,496 | Backorder | |
| 200 mg | $2,323 | Backorder |
| Description | Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression. |
| Synonyms | Ac-Arg-Aib-Arg-α(Me)Phe-NH2 |
| Molecular Weight | 617.756 |
| Formula | C28H47N11O5 |
| Cas No. | 1006388-38-0 |
| Relative Density. | 1.34 g/cm3 (Predicted) |
| Sequence | Ac-Arg-{Aib}-Arg-{aMePhe}-NH2 |
| Sequence Short | Ac-R-{Aib}-R-{aMePhe}-NH2 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.